中金资本旗下基金直投项目——银诺医药于港交所上市

中金资本CICCca...
Aug 15

2025年8月15日,专注于糖尿病及其他代谢性疾病创新疗法的生物医药企业——广州银诺医药集团股份有限公司(以下简称“银诺医药”,股票代码:2591.HK)正式登陆港交所,此次IPO发行价为每股18.68港元。中金资本旗下基金于2021年参与了银诺医药A轮融资。中金公司担任本次项目的联席保荐人、整体协调人、联席全球协调人及联席账簿管理人。关于银诺医药银诺医药成立于2014年,是一家以科学为驱动、专注...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10